Data as of Q4 2025 (Dec 31, 2025)

DERM

(DERM)

Financial Statements · SEC EDGAR XBRL

Net Income
-$14.7M
EPS
$-0.72
Op. Income
-$13.7M
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Operating Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2024
FY 2023
FY 2022
FY 2021
-
$79.2M
$73.7M
$63.1M
-
$79.2M
$73.7M
$63.1M
-
$22.9M
$30.8M
$32.1M
-
$56.3M
$42.9M
$31.1M
-$13.7M
-
-$27.5M
-$34.9M
-$14.7M
-
-$29.6M
-$44.0M
$-0.72
-
$-1.69
$-4.32
$-0.72
-
$-1.69
$-4.32